Ce-224535 clinical trials
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2007
How each study uses ce-224535 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2007 (2)
| Year | Studies |
|---|---|
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2022 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 0
Pfizer (4) · Harmony Biosciences Management, Inc. (1) · Sun Pharma Advanced Research Company Limited (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses ce-224535 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- Drug Interaction Study of ZYN002 Transdermal Gel and Probe SubstratesCompletedPhase 1Harmony Biosciences Management, Inc.NCT06930872Written as Part 2
- A Study in Patients With Advanced Breast CancerTerminatedPhase 1Sun Pharma Advanced Research Company LimitedNCT04942054Written as Part 2
- Study of CE-224,535 A Twice Daily Pill To Control Rheumatoid Arthritis In Patients Who Have Not Totally Improved With MethotrexateCompletedPhase 2PfizerNCT00628095Written as CE-224,535
- A Study Of The Effect Of CE-224535 On Knee OA (Osteoarthritis) PainTerminatedPhase 2PfizerNCT00418782Written as CE-224535
- Study Of The Safety Of CE 224,545 And Methotrexate In Patients With Rheumatoid ArthritisCompletedPhase 1PfizerNCT00446784Written as CE-224,535
- A Study in Normal Healthy People, Testing Different Versions of a Pill That Will be Used to Treat Rheumatoid Arthritis.CompletedPhase 1PfizerNCT00838058Written as CE-224,535
Codes
What other systems call ce-224535 · ClinicalTrials.gg INT005918
- Wikidata Q27088319ce-224535One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27088319 | ce-224535 | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.